Kanika Sehgal, MBBS
Hospital Resident
Research & Publications
Biography
News
Selected Publications
- Sex-Discordant Fecal Microbiota Transplantation for C. difficile may increase risk of post-infection irritable bowel syndrome.Sehgal K, Yadav D, Saha S, Mara K, Grover M, Khanna S. Sex-Discordant Fecal Microbiota Transplantation for C. difficile may increase risk of post-infection irritable bowel syndrome. Gastroenterology 2023 PMID: 38056511, DOI: 10.1053/j.gastro.2023.11.295.
- Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing.Tome J, Sehgal K, Kamboj AK, Harmsen WS, Khanna S, Pardi DS. Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing. Clin Gastroenterol Hepatol 2023, 21: 3125-3131.e2. PMID: 37172800, DOI: 10.1016/j.cgh.2023.04.031.
- The real efficacy of microbiota restoration following standard of care antimicrobial in patients with recurrent Clostridiodes difficileSehgal K, Feuerstadt P. The real efficacy of microbiota restoration following standard of care antimicrobial in patients with recurrent Clostridiodes difficile. Translational Gastroenterology And Hepatology 2023, 8: 31-31. PMID: 38021361, PMCID: PMC10643224, DOI: 10.21037/tgh-23-46.
- The natural history of histological changes in microscopic colitis.Sehgal K, Tome J, Kamboj AK, Dierkhising RA, Pardi DS, Khanna S. The natural history of histological changes in microscopic colitis. Therap Adv Gastroenterol 2023, 16: 17562848231168237. PMID: 37124370, DOI: 10.1177/17562848231168237.
- S220 The Evolving Epidemiology of Colonic Ischemia: A Multi-Center StudySehgal, Kanika MBBS1,*; Rizwan, Rabia MD2; Chaar, Abdelkader MD2; Nawaz, Ahmad MD2; Gnanapandithan, Karthik MD3; Bhutta, Abdul MD4; Fenster, Marc MD5; John, Savio MD6; Brandt, Lawrence MD, MACG7; Feuerstadt, Paul MD, FACG8. S220 The Evolving Epidemiology of Colonic Ischemia: A Multi-Center Study. The American Journal of Gastroenterology 118(10S):p S166-S167, October 2023. | DOI: 10.14309/01.ajg.0000950520.16346.4d
- S170 Development of a Clinically Applicable Prognostication Severity Score for Colon Ischemia in Hospitalized PatientsRizwan, Rabia MD1,*; Amjad, Waseem MD2; Feuerstadt, Paul MD, FACG3; Chaar, AbdelKader MD1; Nawaz, Ahmad MD1; Gnanapandithan, Karthik MD4; Bhutta, Abdul Q. MD5; Fenster, Marc MD6; John, Savio MD7; Sehgal, Kanika MBBS8; Brandt, Lawrence MD, MACG9. S170 Development of a Clinically Applicable Prognostication Severity Score for Colon Ischemia in Hospitalized Patients. The American Journal of Gastroenterology 118(10S):p S128-S129, October 2023. | DOI: 10.14309/01.ajg.0000950320.32814.47
- S285 Malnutrition Status Is an Independent Predictor for Worse Outcomes in Patients Hospitalized With Clostridioides difficile InfectionChaar, AbdelKader MD1,*; Rizwan, Rabia MD1; Nawaz, Ahmad MD1; Patel, Shanti MD1; Aboursheid, Tarek MD2; Sehgal, Kanika MBBS3; Feuerstadt, Paul MD, FACG4. S285 Malnutrition Status Is an Independent Predictor for Worse Outcomes in Patients Hospitalized With Clostridioides difficile Infection. The American Journal of Gastroenterology 118(10S):p S209-S210, October 2023. | DOI: 10.14309/01.ajg.0000950780.96460.41
- Su1867 OUTCOMES OF BEZLOTOXUMAB FOR THE PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION IN PRE-SPECIFIED RISK FACTORS: A MULTI-CENTER EXPERIENCEKanika Sehgal, Abdelkader Chaar, John A. Damianos, Rabia Rizwan, Ahmad Nawaz, Paul Feuerstadt, Su1867 OUTCOMES OF BEZLOTOXUMAB FOR THE PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION IN PRE-SPECIFIED RISK FACTORS: A MULTI-CENTER EXPERIENCE, Gastroenterology, Volume 164, Issue 6, Supplement, 2023, Page S-697, ISSN 0016-5085, https://doi.org/10.1016/S0016-5085(23)02618-5. (https://www.sciencedirect.com/science/article/pii/S0016508523026185)
- Su1868 CLOSTRIDIOIDES DIFFICILE IS ASSOCIATED WITH HIGH RATES OF DEPRESSION WHEN COMPARED WITH OTHER MEDICAL CONDITIONSAbdelkader Chaar, Rabia Rizwan, Ahmad Nawaz, Kanika Sehgal, Yazan Abboud, Paul Feuerstadt, Su1868 CLOSTRIDIOIDES DIFFICILE IS ASSOCIATED WITH HIGH RATES OF DEPRESSION WHEN COMPARED WITH OTHER MEDICAL CONDITIONS, Gastroenterology, Volume 164, Issue 6, Supplement, 2023, Pages S-697-S-698, ISSN 0016-5085, https://doi.org/10.1016/S0016-5085(23)02619-7. (https://www.sciencedirect.com/science/article/pii/S0016508523026197)
- Su1144 EARLY COLONOSCOPY IMPROVES HEALTH CARE UTILIZATION IN LOWER GI BLEEDING: A NATIONWIDE POPULATION-BASED STUDYRabia Rizwan, Abdelkader Chaar, Ahmad Nawaz, Kanika Sehgal, Paul Feuerstadt, Su1144 EARLY COLONOSCOPY IMPROVES HEALTH CARE UTILIZATION IN LOWER GI BLEEDING: A NATIONWIDE POPULATION-BASED STUDY, Gastroenterology, Volume 164, Issue 6, Supplement, 2023, Page S-545, ISSN 0016-5085, https://doi.org/10.1016/S0016-5085(23)02260-6. (https://www.sciencedirect.com/science/article/pii/S0016508523022606)
- Treatment of Clostridioides difficile Infection.Sehgal K, Cifu AS, Khanna S. Treatment of Clostridioides difficile Infection. JAMA 2022, 328: 881-882. PMID: 35939317, DOI: 10.1001/jama.2022.12251.
- The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019.Tome J, Sehgal K, Kamboj AK, Harmsen WS, Kammer PP, Loftus EV, Tremaine WJ, Khanna S, Pardi DS. The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019. Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association 2022, 20: 1085-1094. PMID: 34216819, PMCID: PMC8716639, DOI: 10.1016/j.cgh.2021.06.027.
- Budesonide Maintenance in Microscopic Colitis: Clinical Outcomes and Safety Profile from a Population-Based Study.Tome J, Sehgal K, Kamboj AK, Comstock B, Harmsen WS, Khanna S, Pardi DS. Budesonide Maintenance in Microscopic Colitis: Clinical Outcomes and Safety Profile from a Population-Based Study. The American Journal Of Gastroenterology 2022 PMID: 35417427, DOI: 10.14309/ajg.0000000000001774.
- Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection.Sehgal K, Zandvakili I, Tariq R, Pardi DS, Khanna S. Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection. Expert Review Of Anti-infective Therapy 2022, 20: 577-583. PMID: 34693838, DOI: 10.1080/14787210.2022.1997588.
- Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis.Saha S, Sehgal K, Singh S, Grover M, Pardi D, Khanna S. Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis. Journal Of Clinical Gastroenterology 2022, 56: e84-e93. PMID: 34049374, PMCID: PMC8627535, DOI: 10.1097/MCG.0000000000001536.
- 893: BUDESONIDE MAINTENANCE IN MICROSCOPIC COLITIS: CLINICAL OUTCOMES AND SAFETY PROFILE FROM A POPULATION-BASED STUDYJune Tome, Kanika Sehgal, Amrit K. Kamboj, Bryce Comstock, William S. Harmsen, Sahil Khanna, Darrell S. Pardi, 893: BUDESONIDE MAINTENANCE IN MICROSCOPIC COLITIS: CLINICAL OUTCOMES AND SAFETY PROFILE FROM A POPULATION-BASED STUDY, Gastroenterology, Volume 162, Issue 7, Supplement, 2022, Page S-218, ISSN 0016-5085, https://doi.org/10.1016/S0016-5085(22)60522-5. (https://www.sciencedirect.com/science/article/pii/S0016508522605225)
- Tu1032: GASTROINTESTINAL SYMPTOMS AND PSYCHOLOGICAL DISTRESS AFTER CLOSTRIDIOIDES DIFFICILE INFECTIONKanika Sehgal, Janice Cho, Michael Camilleri, Madhusudan Grover, Darrell S. Pardi, Sahil Khanna, Tu1032: GASTROINTESTINAL SYMPTOMS AND PSYCHOLOGICAL DISTRESS AFTER CLOSTRIDIOIDES DIFFICILE INFECTION, Gastroenterology, Volume 162, Issue 7, Supplement, 2022, Page S-854, ISSN 0016-5085, https://doi.org/10.1016/S0016-5085(22)62021-3. (https://www.sciencedirect.com/science/article/pii/S0016508522620213)
- Su1609: ASSESSING THE GENERALIZABILITY OF RESULTS OF CLOSTRIDIOIDES DIFFICILE CLINICAL TRIALSRyan Pardi, Kanika Sehgal, Sahil Khanna, Darrell S. Pardi, Su1609: ASSESSING THE GENERALIZABILITY OF RESULTS OF CLOSTRIDIOIDES DIFFICILE CLINICAL TRIALS, Gastroenterology, Volume 162, Issue 7, Supplement, 2022, Page S-651, ISSN 0016-5085, https://doi.org/10.1016/S0016-5085(22)61531-2. (https://www.sciencedirect.com/science/article/pii/S0016508522615312)
- S135 Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid TestingTome, June MD1; Sehgal, Kanika MBBS2; Kamboj, Amrit K. MD1; Harmsen, William BS1; Khanna, Sahil MBBS, MS, FACG1; Pardi, Darrell S. MD, MS, FACG1. S135 Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing. The American Journal of Gastroenterology 117(10S):p e98, October 2022. | DOI: 10.14309/01.ajg.0000857180.24034.24
- S197 Real Word Experience of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-analysisSehgal, Kanika MBBS1; Tariq, Raseen MD2; Pardi, Darrell S. MD, MS, FACG2; Khanna, Sahil MBBS, MS, FACG2. S197 Real Word Experience of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-analysis. The American Journal of Gastroenterology 117(10S):p e143, October 2022. | DOI: 10.14309/01.ajg.0000857428.62804.68
- S194 Real World Experience of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Mayo Clinic ExperienceSehgal, Kanika MBBS1; Tariq, Raseen MD2; Pardi, Darrell S. MD, MS, FACG2; Khanna, Sahil MBBS, MS, FACG2. S194 Real World Experience of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Mayo Clinic Experience. The American Journal of Gastroenterology 117(10S):p e141, October 2022. | DOI: 10.14309/01.ajg.0000857416.51046.7a
- S135 Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid TestingTome, June MD1; Sehgal, Kanika MBBS2; Kamboj, Amrit K. MD1; Harmsen, William BS1; Khanna, Sahil MBBS, MS, FACG1; Pardi, Darrell S. MD, MS, FACG1. S135 Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing. The American Journal of Gastroenterology 117(10S):p e98, October 2022. | DOI: 10.14309/01.ajg.0000857180.24034.24
- 893: BUDESONIDE MAINTENANCE IN MICROSCOPIC COLITIS: CLINICAL OUTCOMES AND SAFETY PROFILE FROM A POPULATION-BASED STUDYJune Tome, Kanika Sehgal, Amrit K. Kamboj, Bryce Comstock, William S. Harmsen, Sahil Khanna, Darrell S. Pardi, 893: BUDESONIDE MAINTENANCE IN MICROSCOPIC COLITIS: CLINICAL OUTCOMES AND SAFETY PROFILE FROM A POPULATION-BASED STUDY, Gastroenterology, Volume 162, Issue 7, Supplement, 2022, Page S-218, ISSN 0016-5085, https://doi.org/10.1016/S0016-5085(22)60522-5. (https://www.sciencedirect.com/science/article/pii/S0016508522605225)
- Gut microbiota: a target for intervention in obesity.Sehgal K, Khanna S. Gut microbiota: a target for intervention in obesity. Expert Review Of Gastroenterology & Hepatology 2021, 15: 1169-1179. PMID: 34329563, DOI: 10.1080/17474124.2021.1963232.
- Gut microbiome and checkpoint inhibitor colitis.Sehgal K, Khanna S. Gut microbiome and checkpoint inhibitor colitis. Intestinal Research 2021, 19: 360-364. PMID: 33249800, PMCID: PMC8566823, DOI: 10.5217/ir.2020.00116.
- Gut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface.Sehgal K, Khanna S. Gut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface. Therapeutic Advances In Gastroenterology 2021, 14: 1756284821994736. PMID: 33747125, PMCID: PMC7905718, DOI: 10.1177/1756284821994736.
- The interplay of Clostridioides difficile infection and inflammatory bowel disease.Sehgal K, Yadav D, Khanna S. The interplay of Clostridioides difficile infection and inflammatory bowel disease. Therapeutic Advances In Gastroenterology 2021, 14: 17562848211020285. PMID: 34104215, PMCID: PMC8170344, DOI: 10.1177/17562848211020285.
- Immune response against Clostridioides difficile and translation to therapy.Sehgal K, Khanna S. Immune response against Clostridioides difficile and translation to therapy. Therapeutic Advances In Gastroenterology 2021, 14: 17562848211014817. PMID: 33995585, PMCID: PMC8111532, DOI: 10.1177/17562848211014817.
- Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection.Sehgal K, Fadel HJ, Tande AJ, Pardi DS, Khanna S. Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection. Infection And Drug Resistance 2021, 14: 1645-1648. PMID: 33953575, PMCID: PMC8089469, DOI: 10.2147/IDR.S305349.
- Fr249 THE EPIDEMIOLOGY OF MICROSCOPIC COLITIS BETWEEN 2011-2019: AN OLMSTED COUNTY, MINNESOTA POPULATION-BASED STUDYJune Tome, Kanika Sehgal, Amrit K. Kamboj, William S. Harmsen, Edward V. Loftus, William J. Tremaine, Sahil Khanna, Darrell S. Pardi, Fr249 THE EPIDEMIOLOGY OF MICROSCOPIC COLITIS BETWEEN 2011-2019: AN OLMSTED COUNTY, MINNESOTA POPULATION-BASED STUDY, Gastroenterology, Volume 160, Issue 6, Supplement, 2021, Page S-278, ISSN 0016-5085, https://doi.org/10.1016/S0016-5085(21)01392-5. (https://www.sciencedirect.com/science/article/pii/S0016508521013925)
- THE NATURAL COURSE OF HISTOLOGICAL CHANGES IN MICROSCOPIC COLITISKanika Sehgal, June Tome, Amrit K. Kamboj, Darrell S. Pardi, Sahil Khanna, Fr246 THE NATURAL COURSE OF HISTOLOGICAL CHANGES IN MICROSCOPIC COLITIS, Gastroenterology, Volume 160, Issue 6, Supplement, 2021, Page S-277, ISSN 0016-5085, https://doi.org/10.1016/S0016-5085(21)01389-5. (https://www.sciencedirect.com/science/article/pii/S0016508521013895)
- Outline Download Cite Share Favorites Permissions ABSTRACTS: ACCEPTED: COLON S149 Body Mass Index Changes After Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionSehgal, Kanika MBBS1; Cho, Janice MD1; Saffouri, George MD2; Dierkhising, Ross MS1; Battaglioli, Eric PhD3; Kashyap, Purna MBBS1; Pardi, Darrell MD, MS1; Khanna, Sahil MBBS, MS1. S149 Body Mass Index Changes After Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. The American Journal of Gastroenterology 116():p S65, October 2021. | DOI: 10.14309/01.ajg.0000773068.26704.ab
- S136 Efficacy of Saccharomyces boulardii for Prevention of Clostridioides difficile Infection: A Systematic Review and Meta-AnalysisTariq, Raseen MD1; Yadav, Devvrat MD1; Tahir, Muhammad Waqas MD2; Sehgal, Kanika MBBS1; Pardi, Darrell MD, MS1; Khanna, Sahil MBBS, MS1. S136 Efficacy of Saccharomyces boulardii for Prevention of Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. The American Journal of Gastroenterology 116():p S59-S60, October 2021. | DOI: 10.14309/01.ajg.0000773016.43460.eb
- S148 Clostridioides difficile Infection in Hospitalized Patients With Cirrhosis Treated for Hepatic EncephalopathySehgal, Kanika MBBS1; Spiceland, Clayton M. MD2; Lennon, Ryan MS1; Pardi, Darrell MD, MS1; Khanna, Sahil MBBS, MS1. S148 Clostridioides difficile Infection in Hospitalized Patients With Cirrhosis Treated for Hepatic Encephalopathy. The American Journal of Gastroenterology 116():p S65, October 2021. | DOI: 10.14309/01.ajg.0000773064.81373.f8
- Su1869 CARDIAC EVENTS IN PATIENTS WITH HEART FAILURE RECEIVING BEZLOTOXUMAB FOR THE PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION – A MULTICENTER STUDYAbdelkader Chaar, Rabia Rizwan, Kanika Sehgal, John A. Damianos, Ahmad Nawaz, Paul Feuerstadt, Su1869 CARDIAC EVENTS IN PATIENTS WITH HEART FAILURE RECEIVING BEZLOTOXUMAB FOR THE PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION – A MULTICENTER STUDY, Gastroenterology, Volume 164, Issue 6, Supplement, 2023, Page S-698, ISSN 0016-5085, https://doi.org/10.1016/S0016-5085(23)02620-3. (https://www.sciencedirect.com/science/article/pii/S0016508523026203)
- S3234 The Association of Microscopic Colitis and Primary Sclerosing CholangitisSehgal, Kanika MBBS; Eaton, John E. MD; Pardi, Darrell MD, MS; Khanna, Sahil MBBS, MS. S3234 The Association of Microscopic Colitis and Primary Sclerosing Cholangitis. The American Journal of Gastroenterology 116():p S1333, October 2021. | DOI: 10.14309/01.ajg.0000786468.70739.c8